Carles Iniesta-Navalón

16PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Toxicology (incl. clinical toxicology)NanomedicineMedical biotechnology diagnostics (incl. biosensors)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 22, 2026
Utility of tolerance assays for real-time management of infliximab infusion reactions.

Rocío Guzmán-Laiz, Carles Iniesta-Navalón, Manuel Ríos-Saorín

|Nov 21, 2025
STRATIfy-PK SCORE: A predictive tool for identifying pharmacokinetic failure risk in anti-TNF-treated patient.

Carles Iniesta-Navalón, Manuel Ríos-Saorín, Lorena Rentero-Redondo

|Nov 15, 2025
Immunogenicity phenotypes and reversal of pharmacokinetic impact in anti-TNF-treated immune-mediated diseases: a real-world study.

Rocío Guzmán-Laiz, Carles Iniesta-Navalón, Manuel Ríos-Saorín

|Aug 30, 2025
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.

Antonio Solana-Altabella, Carles Iniesta-Navalón, Maria Chovi-Trull

|May 09, 2025
Evaluating the Accuracy and Clinical Utility of AFIAS-10 Point of Care Versus Enzyme-Linked Immunosorbent Assay in Therapeutic Drug Monitoring of Infliximab and Adalimumab.

Carles Iniesta-Navalón, Manuel Ríos-Saorín, Rebeca Añez-Castaño

|Apr 03, 2025
External Evaluation of Population Pharmacokinetic Models of Ustekinumab in Patients with Inflammatory Bowel Disease.

Carles Iniesta-Navalón, Manuel Ríos Saorín, Juan Manuel Neira-Torrecillas

Pageof 3

Frequent Collaborators

5 joint publications

Mayte Gil-Candel

1 joint publications

Juan Jose Gascón-Cánovas

1 joint publications

Zenewton André da Silva Gama

1 joint publications

José Francisco Sánchez-Ruiz